Cytotoxic effects of anticancer agents on subconfluent and multilayered postconfluent cultures

Eur J Cancer. 1993;29A(11):1566-73. doi: 10.1016/0959-8049(93)90296-r.

Abstract

The cytotoxic effects of conventional (doxorubicin, 5-fluorouracil, cisplatin) and investigational (2',2'-difluorodeoxycytidine, hexadecylphosphocholine, EO9, rhizoxin) anticancer drugs were studied in subconfluent and multilayered postconfluent cultures of human colon and ovarian carcinoma cell lines. Chemosensitivity was assessed 4 days after a 24-h drug exposure with the sulphorhodamine B assay. Except for rhizoxin, all drugs tested yielded an EC50 (drug concentration producing absorbance readings 50% lower than those of non-treated wells) in postconfluent cultures that were higher than an EC50 obtained with subconfluent cultures. Compared with subconfluent cultures, postconfluent cultures showed decreased cellular nucleotide concentrations and ATP/ADP ratios, in addition to an increased percentage of G0/G1 cells. The activity of DT-diaphorase, a reductase involved in the bioactivation of EO9, was similar in sub- and postconfluent cultures. These results indicate similarity of the postconfluent model presented with those obtained with in vivo models and more complex in vitro techniques.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cell Cycle
  • Cell Division / drug effects
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • NAD(P)H Dehydrogenase (Quinone) / metabolism
  • Tumor Cells, Cultured / drug effects*

Substances

  • Antineoplastic Agents
  • NAD(P)H Dehydrogenase (Quinone)